Family Medicine · Jacksonville, FL
NPI
1871518787
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7451 103rd St Ste 8
Jacksonville, FL, 32210
Phone (904) 683-4968
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,192 services
Medicare patients, 2024
124
Average age 72
Drug cost, 2024
$1.8M
17,365 prescriptions
Company payments, 2025
$513
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick P Bunyi was code 99214 (office e&m - established), 447 times for 119 patients. In total Patrick P Bunyi billed 1,192 services in 44 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 447 | 119 | $85.99 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 320 | 98 | $11.76 | $3,764 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 63 | 63 | $17.71 | $1,115 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 62 | 62 | $125.79 | $7,799 |
| 99213 Office E&M - Established | Office | 41 | 33 | $61.69 | $2,529 |
| 82962 Clinical Chemistry | Office | 15 | 11 | $3.21 | $48.15 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $31.66 | $443 |
| 90662 Vaccine Product | Office | 14 | 14 | $81.11 | $1,136 |
| 81003 Clinical Chemistry | Office | 14 | 12 | $2.20 | $30.8 |
| 36415 Venipuncture Blood Collection | Office | 12 | 12 | $8.65 | $104 |
| 99204 Office E&M - New | Office | 12 | 12 | $65.08 | $781 |
By year: 2022 $59K for 1,503 services; 2023 $52K for 912 services; 2024 $62K for 1,192 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 15 | 11 | $3.21 | $48.15 |
| 81003 Clinical Chemistry | 14 | 12 | $2.20 | $30.8 |
| 36415 Venipuncture Blood Collection | 12 | 12 | $8.65 | $104 |
Medicare prescription drug claims, 2024
In 2024, the drug Patrick P Bunyi prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 745 prescriptions and refills. In total Patrick P Bunyi wrote 17,365 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 745 | 745 | 90 | $20K |
| Amlodipine Besylate Generic | 740 | 1,858 | 212 | $4,084 |
| Atorvastatin Calcium Generic | 736 | 1,987 | 228 | $5,243 |
| Losartan Potassium Generic | 639 | 1,617 | 178 | $4,724 |
| Gabapentin Generic | 489 | 735 | 113 | $7,532 |
| Metformin Hcl Generic | 352 | 917 | 103 | $1,896 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 322 | 456 | 79 | $9,485 |
| Lisinopril Generic | 313 | 773 | 83 | $2,163 |
| Omeprazole Generic | 283 | 674 | 81 | $5,537 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 264 | 268 | 31 | $40K |
| Levothyroxine Sodium Generic | 257 | 697 | 71 | $2,013 |
| Alprazolam Generic | 254 | 254 | 30 | $650 |
| Furosemide Generic | 241 | 486 | 69 | $1,052 |
| Hydrochlorothiazide Generic | 237 | 623 | 81 | $939 |
| Fluticasone Propionate Generic | 222 | 463 | 72 | $3,908 |
Brand drugs: 1,880 claims; generic drugs: 15,317 claims; opioid claims: 1,238.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick P Bunyi $513 ($513 in general payments such as food, travel and fees) from 11 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $108.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $108 |
| GlaxoSmithKline, LLC. GSK | 5 | $106 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $82.17 |
| Abbvie Inc. ABBV | 2 | $48.35 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $45.57 |
| Pfizer Inc. PFE | 2 | $36.6 |
| Scpharmaceuticals Inc. SCPH | 1 | $20.63 |
| Indivior Inc. INDV | 1 | $18.36 |
| Exact Sciences Corporation EXAS | 1 | $17.18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.